Kommentar
Tubo-Ovarian Cancer Risk Reduction Counseling for BRCA1/2 Carriers
JAMA Surgery · 01.11.2026 · 161 (11) · 1199
DOI: 10.1001/jamasurg.2026.4347 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Surgery, erschienen am 01.11.2026. Verfasst von Christina Curtin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic Surgery, Department of Surgery, Memorial Sloan Kettering, New York, New York. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Gynecologic Surgery, Department of Surgery, Memorial Sloan Kettering, New York, New York.
- Gynecologic Medical Oncology, Department of Medicine, Memorial Sloan Kettering, New York, New York.
- Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering, New York, New York.
Zitieren
APA
Curtin, C., Liu, Y. L., & Long, K. C. (2026). Tubo-Ovarian Cancer Risk Reduction Counseling for BRCA1/2 Carriers. JAMA Surgery, 161(11), 1199. https://doi.org/10.1001/jamasurg.2026.4347
Vancouver
Curtin C, Liu YL, Long KC. Tubo-Ovarian Cancer Risk Reduction Counseling for BRCA1/2 Carriers. JAMA Surgery. 2026;161(11):1199. doi:10.1001/jamasurg.2026.4347
BibTeX
@article{Curtin2026,
author = {Curtin, Christina and Liu, Ying L and Long, Kara C},
title = {Tubo-Ovarian Cancer Risk Reduction Counseling for BRCA1/2 Carriers},
journal = {JAMA Surgery},
year = {2026},
volume = {161},
number = {11},
pages = {1199},
doi = {10.1001/jamasurg.2026.4347}
}
EUVIMED